T.MAN Pharmaceutical PCL (BKK:TMAN) Interest Expense: ฿-25 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BKK:TMAN T.MAN Pharmaceutical PCL BKK:TMAN
21 GF Score
Price ฿11.00
! 2 Warning Signs
View Full Analysis

What is T.MAN Pharmaceutical PCL Interest Expense?

T.MAN Pharmaceutical PCL BKK:TMAN 21 Interest Expense is ฿-25 Mil as of Mar. 2026. GuruFocus rates BKK:TMAN with a GF Score™ of 21/100. The stock has 2 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. T.MAN Pharmaceutical PCL's interest expense for the three months ended in Mar. 2026 was ฿ -5 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was ฿-25 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. T.MAN Pharmaceutical PCL's Operating Income for the three months ended in Mar. 2026 was ฿ 144 Mil. T.MAN Pharmaceutical PCL's Interest Expense for the three months ended in Mar. 2026 was ฿ -5 Mil. T.MAN Pharmaceutical PCL's Interest Coverage for the quarter that ended in Mar. 2026 was 31.10. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

T.MAN Pharmaceutical PCL  (BKK:TMAN) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

T.MAN Pharmaceutical PCL's Interest Expense for the three months ended in Mar. 2026 was ฿-5 Mil. Its Operating Income for the three months ended in Mar. 2026 was ฿144 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was ฿64 Mil.

T.MAN Pharmaceutical PCL's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2026 )/Interest Expense (Q: Mar. 2026 )
=-1*144.461/-4.645
=31.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

T.MAN Pharmaceutical PCL Interest Expense Historical Data

* Premium members only.

The historical data trend for T.MAN Pharmaceutical PCL's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

T.MAN Pharmaceutical PCL Interest Expense Chart

T.MAN Pharmaceutical PCL Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Interest Expense
-16.98 -14.85 -18.63 -28.44

T.MAN Pharmaceutical PCL Quarterly Data
Dec22 Jun23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.32 -7.55 -6.76 -5.81 -4.65
BKK:TMAN
21GF Score
T.MAN Pharmaceutical PCL BKK:TMAN
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

T.MAN Pharmaceutical PCL Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ฿-25 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of ฿-25 Mil mean?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a Interest Expense of ฿-25 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on T.MAN Pharmaceutical PCL and its competitors.
Is T.MAN Pharmaceutical PCL's Interest Expense too high?
T.MAN Pharmaceutical PCL's current Interest Expense is ฿-25 Mil. Overall, T.MAN Pharmaceutical PCL has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does T.MAN Pharmaceutical PCL's Interest Expense compare to ZTS and UTHR?
T.MAN Pharmaceutical PCL's Interest Expense of ฿-25 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Drug Manufacturers company?
A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on T.MAN Pharmaceutical PCL and its competitors. T.MAN Pharmaceutical PCL's current Interest Expense is ฿-25 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is T.MAN Pharmaceutical PCL stock overvalued right now?
T.MAN Pharmaceutical PCL (BKK:TMAN) has a current Interest Expense of ฿-25 Mil. The current Interest Expense is ฿-25 Mil. T.MAN Pharmaceutical PCL's overall GF Score™ is 21/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For T.MAN Pharmaceutical PCL (BKK:TMAN), the current Interest Expense is ฿-25 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

T.MAN Pharmaceutical PCL Business Description

Address Bangkhunthian Road, 69/1 Soi Bangkhunthian 14, Samaedum Subdistrict, Bangkhunthian District, Bangkok, THA, 10150
T.MAN Pharmaceutical PCL is engaged in purchasing, importing, manufacturing, and distributing original equipment and in manufacturing, distributing, and exporting modern medicines, traditional medicines, dietary supplements, and healthcare products for the healthcare industry. It offers products through brands such as T.Nutrition, T.Derma, Mommy&Me, TMT, Heaven Herb, and T.Pharmaceutical. The company's reportable segments are: Segment for manufactured products under own brand, which derives key revenue, Segment for manufactured products under third parties' brand, and Segment for trading products.
21GF Score

Get the complete analysis for BKK:TMAN

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿11.00
Price